PHIO PHARMACEUTICALS CORP. Lease Obligation Incurred
PHIO PHARMACEUTICALS CORP. (PHIO) reported Lease Obligation Incurred of $620.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-26.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalLeaseObligationsIncurred · last filed 2020-03-26
- PHIO PHARMACEUTICALS CORP. lease obligation incurred for the quarter ending 2019-12-31 was $0.00.
- PHIO PHARMACEUTICALS CORP. lease obligation incurred for the quarter ending 2019-09-30 was $0.00.
- PHIO PHARMACEUTICALS CORP. lease obligation incurred for the quarter ending 2019-06-30 was $0.00.
- PHIO PHARMACEUTICALS CORP. lease obligation incurred for the quarter ending 2019-03-31 was $620.00K.
- PHIO PHARMACEUTICALS CORP. lease obligation incurred for fiscal 2019 was $620.00K.
- PHIO PHARMACEUTICALS CORP. lease obligation incurred for fiscal 2018 was $0.00.
| Period end | Lease Obligation Incurred 3 month | Lease Obligation Incurred 6 month | Lease Obligation Incurred 9 month | Lease Obligation Incurred 12 month | Lease Obligation Incurred 111 month | Lease Obligation Incurred 114 month | Lease Obligation Incurred 117 month |
|---|---|---|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $0.00 derived: sum of 2 quarters · filed 2020-03-26 | $0.00 derived: sum of 3 quarters · filed 2020-03-26 | $620.00K 10-K · filed 2020-03-26 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $620.00K 10-Q · filed 2019-11-12 | $620.00K derived: sum of 4 quarters · filed 2020-03-26 | |||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $620.00K 10-Q · filed 2019-08-12 | $620.00K derived: sum of 3 quarters · filed 2020-03-26 | $620.00K derived: sum of 4 quarters · filed 2020-03-26 | |||
| 2019-03-31 | $620.00K 10-Q · filed 2019-05-14 | $620.00K derived: sum of 2 quarters · filed 2020-03-26 | $620.00K derived: sum of 3 quarters · filed 2020-03-26 | $620.00K derived: sum of 4 quarters · filed 2020-03-26 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $0.00 derived: sum of 2 quarters · filed 2020-03-26 | $0.00 derived: sum of 3 quarters · filed 2020-03-26 | $0.00 10-K · filed 2020-03-26 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $0.00 10-Q · filed 2019-08-12 | |||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-14 | ||||||
| 2012-09-30 | $0.00 derived: 10-Q 117 month − 10-Q 114 month · filed 2012-11-13 | $0.00 derived: sum of 2 quarters · filed 2012-11-13 | $50.00K 10-Q · filed 2012-11-13 | ||||
| 2012-06-30 | $0.00 derived: 10-Q 114 month − 10-Q 111 month · filed 2012-08-14 | $50.00K 10-Q · filed 2012-08-14 | |||||
| 2012-03-31 | $50.00K 10-Q · filed 2012-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |